Abcuro is a Biotech company based in Durham, North Carolina. It has raised $200M in total funding. Latest round: Series C.
Abcuro is a Biotech company based in Durham, North Carolina. Abcuro has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in February 2025. The round record for Abcuro runs through 2025; nothing later has been disclosed. Investors on record include NEA, Foresite Capital, RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital and 8 others. 14 distinct backers are named across the disclosed rounds.
We update the Abcuro record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Durham and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026